On June 27, the FDA approved MannKind’s Afrezza for type 1 and type 2 diabetes, a new rapid-acting inhaled insulin. We’ve been following this story for years in diaTribe...

German pharmaceutical company Merck KGaA has launched a pilot program in Kenya and Uganda to improve the outcomes of diabetes care through a text messaging campaign...

In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...

On May 7, the results of the SEARCH for Diabetes in Youth study published in JAMA found a 21% increase in type 1 diabetes and 31% rise in type 2 diabetes in children...

How can we build healthier cities? What city needs the most help? Please contribute to our reader poll!

At the end of March, encouraging news about Takeda’s once-daily pill for type 2 diabetes, Nesina (alogliptin), circulated at the American College of Cardiology (ACC)...

On March 18, NeuroMetrix launched the second-generation version of its Sensus pain management device, The Sensus is designed to relieve the pain and numbness often...

Diabetes can be exhausting – how do you stay motivated? Adam shares six tips you can apply right now…

Diagnosed with type 2 diabetes? Have a parent or a friend recently diagnosed? The top ten things to know from co-managing editor Adam Brown!

In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.

All you need to know about diabetic neuropathy - the facts, prevention, and treatment.

Last month, the Fight4MyFeet campaign launched to increase awareness of diabetic foot ulcers among people with diabetes, including a host of valuable tips on how to...

On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...

We travel to Oregon to support test strip access for people with diabetes. Find out what transpired!

All about diabetic macular edema (DME) and three tips for avoiding it.

A major need for the 79 million Americans with prediabetes…

How do you stay healthy and happy with diabetes? Kerri shares five lessons she has learned over the years.

Kerri reflects on what a cure means to her.

Adam discovers why sleep is critical to diabetes control.

On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and Ryzodeg (insulin degludec/aspart). Tresiba is Novo Nordisk’...